Pharma channel feed

Phar­ma in­dus­try rep­u­ta­tion scores pos­i­tive bump from in­sulin pric­ing news — Har­ris Poll

3 years ago
Marketing

US gov­ern­ment to SCO­TUS: Take up the Te­va-GSK 'skin­ny' gener­ic drug la­bel case

3 years ago
Law

GAO to NIH: Strength­en over­sight of an­i­mal wel­fare for over­seas con­tracts

3 years ago

US House as­sem­bles bi­par­ti­san cau­cus on do­mes­tic phar­ma man­u­fac­tur­ing

3 years ago
Manufacturing

Sen­ate Fi­nance Com­mit­tee lobs more bi­par­ti­san pres­sure on­to PBMs

3 years ago

MPP re­cruits three gener­ic man­u­fac­tur­ers to ex­pand use of Vi­iV's in­jectable PrEP drug

3 years ago
Deals
Manufacturing

Re­al pa­tient ‘cham­pi­ons’ liv­ing with HIV star in Ther­at­e­ch­nolo­gies cam­paign

3 years ago
Marketing

Ac­qui­si­tion talks on­go­ing for Swedish rare dis­ease biotech Egetis, shares up al­most 40%

3 years ago
Deals

Lu­pus drug de­vel­op­ment mar­ket heat­ing up, while FDA links with ad­vo­ca­cy group to fur­ther ac­cel­er­ate re­search

3 years ago
FDA+
Marketing

Mod­er­na so­lid­i­fies deal with Kenya to build mR­NA man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Deals
Manufacturing

Ther­mo Fish­er moves on cam­pus with new cell man­u­fac­tur­ing site in San Fran­cis­co

3 years ago
Manufacturing

GSK picks up Scynex­is' FDA-ap­proved an­ti­fun­gal drug for $90M up­front

3 years ago
Deals

Q&A: New­ly-mint­ed CSL chief ex­ec­u­tive Paul McKen­zie and chief med­ical of­fi­cer Bill Mez­zan­otte

3 years ago
People

Big Phar­ma-part­nered clin­i­cal tri­al match­mak­er se­cures $20M to im­prove plat­form

3 years ago
Financing

Ot­su­ka, Lund­beck eye Alzheimer's in­di­ca­tion in FDA ad­comm for Rex­ul­ti la­bel ex­pan­sion

3 years ago
FDA+

Boehringer re­ports ro­bust sales led by type 2 di­a­betes and pul­monary drugs, promis­es more to come high­light­ing obe­si­ty

3 years ago
Marketing

FDA ap­proves Nar­can opi­oid over­dose re­ver­sal spray for over-the-counter sale

3 years ago
FDA+
Marketing

J&J bows out of RSV vac­cine race, end­ing PhI­II study and ced­ing to Pfiz­er, GSK

3 years ago
R&D

As­traZeneca ax­es li­cense agree­ment with Aridis, plac­ing Eu­rope-fund­ed PhI­II on hold

3 years ago
Deals

Ohio at­tor­ney gen­er­al sues sev­er­al PBMs over an­titrust con­cerns

3 years ago
Law

Phar­ma ad to­tal tops $8B again in 2022, led by top brands from Sanofi and Re­gen­eron, Ab­b­Vie

3 years ago
Marketing

House com­mit­tee to in­ves­ti­gate FDA's re­sponse to on­go­ing drug short­ages

3 years ago
FDA+
Manufacturing

Q&A: Pfiz­er cor­po­rate com­mu­ni­ca­tions chief Sal­ly Sus­man dis­cuss­es book craft­ed in pan­dem­ic and per­son­al lessons

3 years ago
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie dri­ves en­dometrio­sis aware­ness; No­var­tis adds to Cosen­tyx cam­paign

3 years ago
Marketing
First page Previous page 135136137138139140141 Next page Last page
A service from the Financial Times